Medicare Enrolled

Dr. Kyle Linsey, D.O.

Dermatology · Clearwater, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
610 LAKEVIEW RD, Clearwater, FL 33756
7274467578
In practice since 2013 (12 years)
NPI: 1194164517 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Linsey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Linsey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Linsey

Dr. Kyle Linsey is a dermatology specialist in Clearwater, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Linsey performed 17,413 Medicare services across 3,210 unique beneficiaries.

Between the years covered by Open Payments, Dr. Linsey received a total of $2,745 from 27 pharmaceutical and/or device companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Linsey is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 1% volume in FL $2,745 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 12404 Clear March 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
17,413
Medicare services
Top 1% in FL for dermatology
3,210
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,451 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
11,940 $29 $56
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,970 $90 $190
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
1,432 $26 $55
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
374 $79 $184
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
317 $85 $171
Aflibercept eye injection (Eylea) 236 $698 $1,336
Injection, bimatoprost, intracameral implant, 1 microgram 210 $162 $309
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
140 $45 $91
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
116 $154 $317
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
111 $329 $648
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
92 $18 $40
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
91 $998 $1,909
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
87 $111 $252
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
43 $30 $59
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
37 $23 $54
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
35 $31 $69
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
32 $184 $362
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
29 $12 $23
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
25 $17 $36
Laser release of scar tissue between lens and retina
A laser procedure used to remove scar tissue located between the lens and the retina of the eye.
23 $306 $584
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $61 $134
Medication injection into the eye
A procedure involving the injection of medication directly into the eye. The specific type of medication or clinical purpose is not defined in the provided description.
21 $136 $259
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $41 $83
Extended color vision testing
A comprehensive eye exam that includes specialized tests to evaluate color vision.
14 $41 $78
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,745
Total received (2018-2024)
Avg $392/year across 7 years
Top 12% in FL for dermatology
27
Companies
135
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,489 (90.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256 (9.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$664
2023
$310
2022
$722
2021
$707
2020
$113
2019
$116
2018
$113

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$350
Sun Pharmaceutical Industries Inc.
$348
ABBVIE INC.
$291
Bausch & Lomb Americas Inc.
$284
Notal Vision, Inc.
$256
Kala Pharmaceuticals, Inc.
$177
SUN PHARMACEUTICAL INDUSTRIES INC.
$152
Alcon Vision LLC
$98
Genentech USA, Inc.
$98
Novartis Pharmaceuticals Corporation
$96
Bausch & Lomb, a division of Bausch Health US, LLC
$86
Tarsus Pharmaceuticals, Inc.
$78
Horizon Therapeutics plc
$63
Eyevance Pharmaceuticals LLC
$63
Astellas Pharma US Inc
$58
Shire North American Group Inc
$41
Sight Sciences, Inc.
$27
Apellis Pharmaceuticals, Inc.
$25
Akorn Operating Company LLC
$24
Johnson & Johnson Surgical Vision, Inc.
$22
Harrow Eye, LLC
$20
EYEVANCE PHARMACEUTICALS LLC
$19
Carl Zeiss Meditec Cataract Technology Inc.
$16
Optos, Inc.
$15
Dompe US, Inc.
$13
Aerie Pharmaceuticals, Inc.
$12
Allergan Inc.
$11
Top 3 companies account for 36.1% of total payments
Associated products mentioned in payments ›
ALPHAGAN P · ARGOS · BOTOX · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Catalyst System · Cequa · Clareon · DURYSTA · ENVISTA · EYSUVIS · Flarex · IHEEZO · INVELTYS · Izervay · LOTEMAX SM · LUMIGAN · MIEBO · Oxervate · PANORAMIC OPHTHALMOSCOPE · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · Syfovre · TEPEZZA · TearCare SmartLid · TobraDex ST · Tobradex ST · VABYSMO · VICTUS · VUITY · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $16 per 100 Medicare services performed
Looking for a dermatology specialist in Clearwater?
Compare dermatologists in the Clearwater area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
182
Per 100K population
18.9
County median income
$70,293
Nearest hospital
MORTON PLANT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Linsey is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement in the top 12% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Linsey experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Linsey performed 11,940 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Linsey receive payments from pharmaceutical companies?
Yes. Dr. Linsey received a total of $2,745 from 27 companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Linsey's costs compare to other dermatologists in Clearwater?
Dr. Linsey's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Linsey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →